Literature DB >> 30324356

Safety of a Modified Community Trailer to Manage Patients with Presumed Fentanyl Overdose.

Frank X Scheuermeyer1, Eric Grafstein2, Jane Buxton2, Keith Ahamad2, Mark Lysyshyn2, Stan DeVlaming2, Gerrit Prinsloo2, Christopher Van Veen2, Andrew Kestler2, Reka Gustafson2.   

Abstract

Opioid overdoses (OD) cause substantial morbidity and mortality globally, and current emergency management is typically limited to supportive care, with variable emphasis on harm reduction and addictions treatment. Our urban setting has a high concentration of patients with presumed fentanyl OD, which places a burden on both pre-hospital and emergency department (ED) resources. From December 13, 2016, to March 1, 2017, we placed a modified trailer away from an ED but near the center of the expected area of high OD and accepted low-risk patients with presumed fentanyl OD. We provided OD treatment as well as on-site harm reduction, addictions care, and community resources. The primary outcome was the proportion of patients requiring transfer to an ED for clinical deterioration, while secondary outcomes were the proportion of patients initiated on opioid agonists and provided take-home naloxone kits. We treated 269 patients with opioid OD, transferred three (1.1%) to a local ED, started 43 (16.0%) on opioid agonists, and provided 220 (81.7%) with THN. Our program appears to be safe and may serve as a model for other settings dealing with a large numbers of opioid OD.

Entities:  

Keywords:  Addictions medicine; Fentanyl; Opioid overdose; Public health

Mesh:

Substances:

Year:  2019        PMID: 30324356      PMCID: PMC6391297          DOI: 10.1007/s11524-018-0321-z

Source DB:  PubMed          Journal:  J Urban Health        ISSN: 1099-3460            Impact factor:   3.671


  13 in total

1.  Factors Associated With Participation in an Emergency Department-Based Take-Home Naloxone Program for At-Risk Opioid Users.

Authors:  Andrew Kestler; Jane Buxton; Gray Meckling; Amanda Giesler; Michelle Lee; Kirsten Fuller; Hong Quian; Dalya Marks; Frank Scheuermeyer
Journal:  Ann Emerg Med       Date:  2016-10-10       Impact factor: 5.721

2.  Fatal Fentanyl: One Pill Can Kill.

Authors:  Mark E Sutter; Roy R Gerona; M Thais Davis; Bailey M Roche; Daniel K Colby; James A Chenoweth; Axel J Adams; Kelly P Owen; Jonathan B Ford; Hugh B Black; Timothy E Albertson
Journal:  Acad Emerg Med       Date:  2016-10-31       Impact factor: 3.451

3.  Should Buprenorphine Be Administered to Patients With Opioid Withdrawal in the Emergency Department?

Authors:  Jennifer S Love; Jeanmarie Perrone; Lewis S Nelson
Journal:  Ann Emerg Med       Date:  2017-11-03       Impact factor: 5.721

Review 4.  Do heroin overdose patients require observation after receiving naloxone?

Authors:  Michael W Willman; David B Liss; Evan S Schwarz; Michael E Mullins
Journal:  Clin Toxicol (Phila)       Date:  2016-11-16       Impact factor: 4.467

5.  Emergency department-initiated buprenorphine/naloxone treatment for opioid dependence: a randomized clinical trial.

Authors:  Gail D'Onofrio; Patrick G O'Connor; Michael V Pantalon; Marek C Chawarski; Susan H Busch; Patricia H Owens; Steven L Bernstein; David A Fiellin
Journal:  JAMA       Date:  2015-04-28       Impact factor: 56.272

6.  Notes from the Field: Furanyl-Fentanyl Overdose Events Caused by Smoking Contaminated Crack Cocaine - British Columbia, Canada, July 15-18, 2016.

Authors:  Salman A Klar; Elizabeth Brodkin; Erin Gibson; Shovita Padhi; Christine Predy; Corey Green; Victoria Lee
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2016-09-23       Impact factor: 17.586

7.  China White epidemic: an eastern United States emergency department experience.

Authors:  M Martin; J Hecker; R Clark; J Frye; D Jehle; E J Lucid; F Harchelroad
Journal:  Ann Emerg Med       Date:  1991-02       Impact factor: 5.721

8.  Opioid substitution treatment is linked to reduced risk of death in opioid use disorder.

Authors:  Ajay Manhapra; Robert Rosenheck; David A Fiellin
Journal:  BMJ       Date:  2017-04-26

Review 9.  Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies.

Authors:  Luis Sordo; Gregorio Barrio; Maria J Bravo; B Iciar Indave; Louisa Degenhardt; Lucas Wiessing; Marica Ferri; Roberto Pastor-Barriuso
Journal:  BMJ       Date:  2017-04-26

10.  Vital Signs: Trends in Emergency Department Visits for Suspected Opioid Overdoses - United States, July 2016-September 2017.

Authors:  Alana M Vivolo-Kantor; Puja Seth; R Matthew Gladden; Christine L Mattson; Grant T Baldwin; Aaron Kite-Powell; Michael A Coletta
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2018-03-09       Impact factor: 17.586

View more
  1 in total

1.  Cohort profile: The provincial substance use disorder cohort in British Columbia, Canada.

Authors:  Fahmida Homayra; Lindsay A Pearce; Linwei Wang; Dimitra Panagiotoglou; Tamunoibim F Sambo; Neale Smith; Rachael McKendry; Bonnie Wilson; Ronald Joe; Ken Hawkins; Rolando Barrios; Craig Mitton; Bohdan Nosyk
Journal:  Int J Epidemiol       Date:  2021-01-23       Impact factor: 7.196

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.